Cargando…

Hypercapnic acidosis induces mitochondrial dysfunction and impairs the ability of mesenchymal stem cells to promote distal lung epithelial repair

Acute respiratory distress syndrome (ARDS) is a devastating disorder characterized by diffuse inflammation and edema formation. The main management strategy, low tidal volume ventilation, can be associated with the development of hypercapnic acidosis (HCA). Mesenchymal stem cells (MSCs) are a promis...

Descripción completa

Detalles Bibliográficos
Autores principales:	Fergie, Nicola, Todd, Naomi, McClements, Lana, McAuley, Danny, O’Kane, Cecilia, Krasnodembskaya, Anna
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Federation of American Societies for Experimental Biology 2019
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6436662/ https://www.ncbi.nlm.nih.gov/pubmed/30649987 http://dx.doi.org/10.1096/fj.201802056R

Ejemplares similares

Mesenchymal stromal cell extracellular vesicles rescue mitochondrial dysfunction and improve barrier integrity in clinically relevant models of ARDS
por: Dutra Silva, Johnatas, et al.
Publicado: (2021)

0995. Aspirin reduces neutrophilic pulmonary inflammation in a human model of acute respiratory distress syndrome induced by inhaled lipopolysaccharide
por: Hamid, U Imran, et al.
Publicado: (2014)

Mitochondrial Transfer via Tunneling Nanotubes is an Important Mechanism by Which Mesenchymal Stem Cells Enhance Macrophage Phagocytosis in the In Vitro and In Vivo Models of ARDS
por: Jackson, Megan V., et al.
Publicado: (2016)

Mesenchymal stromal cells-derived extracellular vesicles reprogramme macrophages in ARDS models through the miR-181a-5p-PTEN-pSTAT5-SOCS1 axis
por: Su, Yue, et al.
Publicado: (2023)

Protective effects of hypercapnic acidosis on Ischemia–reperfusion-induced retinal injury
por: Lin, Le-Tien, et al.
Publicado: (2019)

Prevention of post-operative complications by using a HMG-CoA reductase inhibitor in patients undergoing one-lung ventilation for non-cardiac surgery: study protocol for a randomised controlled trial
por: Shyamsundar, Murali, et al.
Publicado: (2018)

Hypercapnic acidosis in ARDS: A tolerated side effect or an important therapeutic modality?
por: Salmon, Adrian A, et al.
Publicado: (2007)

Bench-to-bedside review: Hypercapnic acidosis in lung injury - from 'permissive' to 'therapeutic'
por: Ijland, Marloes M, et al.
Publicado: (2010)

Comparison of the effects of moderate and severe hypercapnic acidosis on ventilation-induced lung injury
por: Yang, Wanchao, et al.
Publicado: (2015)

A Porcine Ex Vivo Lung Perfusion Model To Investigate Bacterial Pathogenesis
por: Dumigan, Amy, et al.
Publicado: (2019)

Metabolic acidosis may be as protective as hypercapnic acidosis in an ex-vivo model of severe ventilator-induced lung injury: a pilot study
por: Kapetanakis, Theodoros, et al.
Publicado: (2011)

Simvastatin decreases the level of heparin-binding protein in patients with acute lung injury
por: McAuley, Daniel F, et al.
Publicado: (2013)

Heterogeneity of treatment effect by baseline risk of mortality in critically ill patients: re-analysis of three recent sepsis and ARDS randomised controlled trials
por: Santhakumaran, Shalini, et al.
Publicado: (2019)

Effects of clinically relevant acute hypercapnic and metabolic acidosis on the cardiovascular system: an experimental porcine study
por: Stengl, Milan, et al.
Publicado: (2013)

Hypercapnic acidosis attenuates pressure-dependent increase in whole-lung filtration coefficient (K(f))
por: Bommakanti, Nikhil, et al.
Publicado: (2017)

Hypercapnic acidosis transiently weakens hypoxic pulmonary vasoconstriction in anesthetized pigs, without affecting the endogenous pulmonary nitric oxide production
por: Nilsson, MC, et al.
Publicado: (2011)

Hypercapnic acidosis attenuates pulmonary epithelial stretch-induced injury via inhibition of the canonical NF-κB pathway
por: Horie, Shahd, et al.
Publicado: (2016)

Protective Effect of Hypercapnic Acidosis in Ischemia-Reperfusion Lung Injury Is Attributable to Upregulation of Heme Oxygenase-1
por: Wu, Shu-Yu, et al.
Publicado: (2013)

The Effects of Lung Protective Ventilation or Hypercapnic Acidosis on Gas Exchange and Lung Injury in Surfactant Deficient Rabbits
por: Hummler, Helmut D., et al.
Publicado: (2016)

Keratinocyte growth factor in acute lung injury to reduce pulmonary dysfunction – a randomised placebo-controlled trial (KARE): study protocol
por: Cross, Laurence JM, et al.
Publicado: (2013)

Erratum to: Keratinocyte growth factor in acute lung injury to reduce pulmonary dysfunction – a randomised placebo-controlled trial (KARE): study protocol
por: Cross, Laurence J. M., et al.
Publicado: (2017)

Prehospital reversal of profound respiratory acidosis and hypercapnic coma by non-invasive ventilation: a report of two cases
por: Fubini, PE, et al.
Publicado: (2020)

A randomized clinical trial of ascorbic acid in open abdominal aortic aneurysm repair
por: Duffy, Martin J, et al.
Publicado: (2015)

Deafness in distal renal tubular acidosis
Publicado: (2013)

Familial distal renal tubular acidosis
por: Zhang, Lihong, et al.
Publicado: (2021)

The relationship between plasma cystatin C, mortality and acute respiratory distress syndrome subphenotype in the HARP-2 trial
por: McKelvey, Michael C., et al.
Publicado: (2023)

Moderate and prolonged hypercapnic acidosis may protect against ventilator-induced diaphragmatic dysfunction in healthy piglet: an in vivo study
por: Jung, Boris, et al.
Publicado: (2013)

Editorial: New Technologies for Women’s Health
por: McClements, Lana, et al.
Publicado: (2022)

The Anti-Migratory Effects of FKBPL and Its Peptide Derivative, AD-01: Regulation of CD44 and the Cytoskeletal Pathway
por: Yakkundi, Anita, et al.
Publicado: (2013)

Emerging pharmacological therapies for ARDS: COVID-19 and beyond
por: Horie, Shahd, et al.
Publicado: (2020)

Baseline plasma IL-18 may predict simvastatin treatment response in patients with ARDS: a secondary analysis of the HARP-2 randomised clinical trial
por: Boyle, Andrew James, et al.
Publicado: (2022)

Hydroxymethylglutaryl-CoA reductase inhibition with simvastatin in Acute lung injury to Reduce Pulmonary dysfunction (HARP-2) trial: study protocol for a randomized controlled trial
por: McAuley, Daniel F, et al.
Publicado: (2012)

Can Stem Cells Beat COVID-19: Advancing Stem Cells and Extracellular Vesicles Toward Mainstream Medicine for Lung Injuries Associated With SARS-CoV-2 Infections
por: Chrzanowski, Wojciech, et al.
Publicado: (2020)

KL-6 in acute lung injury: will it leave its mark?
por: Shyamsundar, Murali, et al.
Publicado: (2008)

Incomplete Distal Renal Tubular Acidosis with Nephrocalcinosis
por: Choi, Joon Seok, et al.
Publicado: (2011)

Evidence for chemokine synergy during neutrophil migration in ARDS
por: Williams, Andrew E, et al.
Publicado: (2017)

Hyperoxaemia and hypoxaemia are associated with harm in patients with ARDS
por: Boyle, Andrew J., et al.
Publicado: (2021)

Role of A Novel Angiogenesis FKBPL-CD44 Pathway in Preeclampsia Risk Stratification and Mesenchymal Stem Cell Treatment
por: Todd, Naomi, et al.
Publicado: (2020)

Elucidating the Pathogenesis of Pre-eclampsia Using In Vitro Models of Spiral Uterine Artery Remodelling
por: McNally, Ross, et al.
Publicado: (2017)

Does Hypercapnic Acidosis, induced by Adding CO(2) to Inspired Gas, Have Protective Effect in a Ventilator-induced Lung Injury?
por: Park, Chang Min, et al.
Publicado: (2005)

Cannot write session to /tmp/vufind_sessions/sess_qob95v6ibmp1s22ba9gbr19b4q